FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
31/10/2023
Voltar para busca
Dado oficial do USPTO
COVIRUPT
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
31
Atualização mais recente
31/10/2023
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5, 42
Data de depósito
11/08/2021
Data de registro
04/07/2023
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
04/07/2023
Última transação
04/07/2023
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
25
Localização do titular
LI
Examinador
LE, KHANH M
Unidade examinadora
M70
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Lysando AG
Representantes
Alan M. Weisberg CHRISTOPHER & WEISBERG, P.A.
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
biochemical and biological preparations and reagents for scientific useother than for medical or veterinary purposes; biological preparations for industrial useother than for medical or veterinary purposes; reagents for industrial research purposesother than for medical or veterinary purposes; biochemical and biological preparations and reagents for research and development in the fields of human and veterinary medicinepharmacybiology and biotechnology; industrial detergents for use in manufacturing processes; detergents for use in industrial manufacturing processes; active biochemical and biological ingredients for use in the manufacture of pharmaceutical preparations for treating viruses; active biochemical and biological additives for use in the manufacture of medical dressings; biochemical and biological additives for use in the manufacture of medicinepharmaceutical preparationsmedical dressings and plasterspersonal care products and sanitary products; biochemical and biological additives and active biochemical and biological ingredients for use in the manufacture of medicines and pharmaceuticals for treating viral infectionsmedical dressings and plasterspersonal care products and sanitary products; biochemical and biological preparationsfor use in the manufacture of pharmaceuticals for treating viral infections; biochemical and biological raw materials for use as active ingredients in the manufacture of pharmaceutical preparations for treating viral infections; biochemical and biological preparations having antimicrobial and/or virucidal properties for scientific research purposes and other than for medical or veterinary purposes; biologicalbiochemical and biotechnological substances for use as additives in the manufacture of personal care products
Classe 5
Medicines for the treatment of viral infections; pharmaceutical preparations for the treatment of viral infections; pharmaceutical preparations in the form of aqueous solutioninhalation solutioninjectable solutions for use in the treatment of viral infections; pharmaceuticals in the form of medicated creamslotionsointments for dermatological use; preparations against infectious agentsdisinfectants; sanitary preparations for medical and veterinary purposes; medicated virucidal mouth and throat washes; medicated products for the treatment of viral infectionsmouth and throat spraysnasal spraysnasal oilsnasal ointmentsnasal creams and nasal drops for medical and veterinary purposes; medicated lozenges for medical purposes; skin disinfectant; medicated skin care preparations; antiseptic wipes for medicalveterinary and surgical purposes; disinfectants; wipes and medical dressings impregnated with disinfectants or virucidal pharmaceutical solutions; disinfecting biochemical and biological preparations for medical and veterinary purposes; virucides for medical or veterinary purposes; polypeptidesnucleic acidsproteinslipidsenzymes and enzyme preparations for medicalveterinary and disinfection purposes; medicated eye washesmedicated eye drops and additives for medicated eye washes and medicated eye drops; animal feed additives for treating infectious diseases; germicides; cleansing preparations with disinfecting effect for hygienic purposes; medicated animal and livestock washes
Classe 42
Scientific research in the field of pharmaceuticals; research and development services and research work in the fields of medicinepharmacybacteriologyvirologyhealth productscosmetics and food supplements; research and development consultancyin particular in the fields of medicinepharmacybacteriologyvirologyhealth productscosmetics and food supplements; industrial analytical and research servicesin particular in the fields of antimicrobial and virucidal analysis and research
Publicações
Histórico de despachos e eventos da marca no USPTO.
31 publicações encontradas
FICS
FINAL DISPOSITION NOTICE SENT TO IB
06/10/2023
FIMP
FINAL DISPOSITION PROCESSED
06/10/2023
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
04/10/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
04/07/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
04/07/2023
GPNX
NOTIFICATION PROCESSED BY IB
25/04/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
18/04/2023
PUBO
PUBLISHED FOR OPPOSITION
18/04/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
05/04/2023
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
05/04/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
29/03/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
14/03/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/03/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/03/2023
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
03/03/2023
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
11/01/2023
GNFR
FINAL REFUSAL E-MAILED
11/01/2023
CNFR
FINAL REFUSAL WRITTEN
11/01/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
15/12/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
14/12/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
14/12/2022
RFNT
REFUSAL PROCESSED BY IB
06/07/2022
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
15/06/2022
RFRR
REFUSAL PROCESSED BY MPU
15/06/2022
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
18/05/2022
CNRT
NON-FINAL ACTION WRITTEN
17/05/2022
DOCK
ASSIGNED TO EXAMINER
12/05/2022
MAFR
APPLICATION FILING RECEIPT MAILED
03/05/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
29/04/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
28/04/2022
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace COVIRUPT ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.